Paraquat Exposure and Parkinson’s Disease Risk in the United States: A Meta-analysis of Epidemiologic Studies
Jamir Pitton Rissardo1, Ana Leticia Fornari Caprara1, Ian M. Walker1
1Cooper University Hospital
Objective:

To quantify the association between paraquat exposure and Parkinson’s disease (PD) risk in U.S.-based studies using meta-analytic methods.

Background:
Paraquat, a widely used herbicide, has been implicated as a potential environmental risk factor for PD. While numerous studies have examined this association globally, regulatory and exposure patterns differ by region. Clarifying the risk in U.S. populations is critical for public health and policy decisions.
Design/Methods:

We conducted a systematic review and meta-analysis of 19 U.S.-based studies assessing paraquat exposure and PD risk. Binary outcome data were synthesized using the Mantel-Haenszel method under fixed- and random-effects models. Between-study variance (τ²) was estimated using the DerSimonian-Laird method, and heterogeneity was assessed with Cochran’s Q and I². Subgroup analyses were performed for occupational, environmental, and mixed exposure categories. Publication bias was evaluated using Egger’s, Begg’s, and Thompson-Sharp tests, as well as trim-and-fill analysis.

Results:

The fixed-effects model yielded an effect size of −0.01 (95% CI: −0.09 to 0.07; p = 0.76), while the random-effects model showed −0.07 (95% CI: −0.30 to 0.15; p = 0.52). The prediction interval ranged from −0.91 to 0.76, indicating substantial uncertainty in true effects across populations. Heterogeneity was statistically significant by Q test (Q = 83.9, p < 0.001) but low by I² (0.8%). Subgroup analyses revealed no significant associations for occupational exposure (OR 0.99; 95% CI, 0.88–1.12), environmental exposure (OR 0.98; 95% CI, 0.87–1.10), or mixed exposure (OR 3.46; 95% CI, 0.38–31.55), with all confidence intervals crossing unity. No evidence of publication bias was detected by Egger’s (p = 0.696), Begg’s (p = 0.916), or trim-and-fill methods.

Conclusions:

Current U.S.-based epidemiologic evidence does not demonstrate a statistically significant association between paraquat exposure and PD risk. Despite low I², the wide prediction interval and significant Q test suggest variability across studies.

10.1212/WNL.0000000000213021
Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff.